Technical Analysis for BHC - Bausch Health Companies Inc.
ADX | Long-Term | Intermediate-Term | Short-Term |
---|---|---|---|
Strong | N/A | Up | Up |
See historical BHC trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Feb 15 | Bollinger Band Squeeze | Range Contraction | 0.00% |
Feb 15 | BB Squeeze Started | Range Contraction | 0.00% |
Feb 12 | NR7 | Range Contraction | 0.30% |
Feb 11 | Pocket Pivot | Bullish Swing Setup | 0.81% |
Feb 8 | Doji - Bullish? | Reversal | 3.66% |
Feb 8 | Down 3 Days in a Row | Weakness | 3.66% |
Feb 7 | Slingshot Bullish | Bullish Swing Setup | 2.87% |
Feb 7 | Upper Bollinger Band Walk | Strength | 2.87% |
Feb 7 | Overbought Stochastic | Strength | 2.87% |
Feb 7 | Gapped Down | Weakness | 2.87% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-02-28
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
S&P/Tsx 60 Index Medicine Biotechnology Laser Psoriasis Acne Actinic Keratosis
S&P/Tsx 60 Index Medicine Biotechnology Laser Psoriasis Acne Actinic Keratosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength | |||
Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. |
See more BHC news...
Indicators
Indicator | Value |
---|---|
52 Week High | 36.52 |
52 Week Low | 23.6 |
Average Volume | 1,027,124 |
200-Day Moving Average | 0.0 |
50-Day Moving Average | 30.3878 |
20-Day Moving Average | 32.4675 |
10-Day Moving Average | 33.383 |
Average True Range | 1.0314 |
ADX | 25.23 |
+DI | 30.8554 |
-DI | 17.5377 |
Chandelier Exit (Long, 3 ATRs ) | 31.4258 |
Chandelier Exit (Short, 3 ATRs ) | 32.5642 |
Upper Bollinger Band | 34.5736 |
Lower Bollinger Band | 30.3614 |
Percent B (%b) | 0.79 |
BandWidth | 12.973589 |
MACD Line | 0.9525 |
MACD Signal Line | 0.9093 |
MACD Histogram | 0.0432 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 35.260 | ||||
Resistance 3 (R3) | 35.367 | 34.943 | 34.995 | ||
Resistance 2 (R2) | 34.943 | 34.538 | 34.890 | 34.907 | |
Resistance 1 (R1) | 34.307 | 34.288 | 34.095 | 34.200 | 34.818 |
Pivot Point | 33.883 | 33.883 | 33.778 | 33.830 | 33.883 |
Support 1 (S1) | 33.247 | 33.478 | 33.035 | 33.140 | 32.522 |
Support 2 (S2) | 32.823 | 33.228 | 32.770 | 32.433 | |
Support 3 (S3) | 32.187 | 32.823 | 32.345 | ||
Support 4 (S4) | 32.080 |